Give us 3 temples, keep 39,997 mosques: Swamy to Muslims

Bengaluru, Feb 26: Congress leaders on Wednesday staged a protest in front of Mahatma Gandhi's statue at Vidhana Soudha here against BJP MLA Basanagouda Patil Yathnal's alleged remarks accusing freedom fighter HS Doreswamy of being a "Pakistani agent".

Former Chief Minister and senior Congress leader Siddaramaiah, KPCC working president Eashwar Khandre also joined the protest.

Yathnal on Tuesday called Doreswamy a fake freedom fighter and a Pakistani agent, while addressing the media.

His comments triggered a controversy drawing sharp remarks from Congress and other parties.

Congress has demanded an apology from Yathnal and has also urged that his Assembly membership be cancelled.

"Session proceedings will not continue until Yathnal apologises," said senior Congress leader HK Patil while addressing the protest earlier today.

Siddaramaiah asserted that making "provocative" comments against such a freedom fighter is obnoxious.

Former KPCC president Dr G Parameshwar said: "Yathnal is a criminal who had mentioned in his election affidavit that he had 27 cases against him. He has made such loose comments against the freedom fighter. He should apologise for his remarks."

Mangaluru, Mar 11: Nitte Education Trust is among the top 50 reputed institutions in the country selected by NITI Aayog for setting up Atal Incubation Centre under Union government's Atal Innovation Mission (AIM) scheme.

NITI Aayog has sanctioned Rs 9 Crore to Nitte Education Trust for setting up a full-fledged Incubation Centre at Nitte, of which Rs 2.5 crores has been received as first instalment according to a press release here on Wednesday.

Atal Incubation Centre- Nitte provides start-ups with valuable guidance, technological aid, access to investors, networking and facilitating a host of other services required for start-ups to survive and scale. Start-ups also receive direction through the robust chain of mentors who give sector-specific information and real-time practical guidance.

New Delhi, Jun 13: Loss of smell or taste has been added to the list of COVID-19 symptoms, according to the revised clinical management protocols released by the Union Health Ministry on Saturday.

The ministry said that coronavirus-infected patients reporting to various COVID-19 treatment facilities have been reporting symptoms like fever, cough, fatigue, shortness of breath, expectoration, myalgia, rhinorrhea, sore throat and diarrhea.

They have also complained of loss of smell (anosmia) or loss of taste (ageusia) preceding the onset of respiratory symptoms.

Older people and immune-suppressed patients in particular may present with atypical symptoms such as fatigue, reduced alertness, reduced mobility, diarrhoea, loss of appetite, delirium, and absence of fever, the ministry said.

Children might not have reported fever or cough as frequently as adults.

The US's national public health institute, the Centers for Disease Control and Prevention (CDC), had in early May incorporated "a new loss of taste or smell" in the list of COVID-19 symptoms.

According to the data from Integrated Health Information Platform and Integrated Disease Surveillance Programme, portal case investigation forms for COVID 19 (n=15,366), the details on the signs and symptoms reported are (as on June 11), fever (27 per cent), cough (21 pc), sore throat (10 pc), breathlessness (8 pc), Weakness (7 pc), running nose (3pc ) and others 24 pc.

According to the health ministry, people infected by the novel coronavirus are the main source of infection.

Direct person-to-person transmission occurs through close contact, mainly through respiratory droplets that are released when the infected person coughs, sneezes, or talks.

These droplets may also land on surfaces, where the virus remains viable. Infection can also occur if a person touches an infected surface and then touches his or her eyes, nose, or mouth.

The median incubation period is 5.1 days (range 2–14 days). The precise interval during which an individual with COVID-19 is infectious is uncertain.

As per the current evidence, the period of infectivity starts 2 days prior to onset of symptoms and lasts up to 8 days.

The extent and role played by pre-clinical/ asymptomatic infections in transmission still remain under investigation.